drugset
drugset / Trial / NCT00652912

Bioavailability Study of Clonazepam ODT Under Fasting Conditions

NCT00652912 ↗

Phase 1 Completed 32 enrolled Par Pharmaceutical, Inc. Cetero Research, San Antonio · collab
RandomizedCrossoverOpen-label

Summary

To compare the single-dose bioavailability of Clonazepam ODT 1 mg and Klonopin Wafers 1 mg ODT

Timeline

Start
2004-03
Primary completion
2004-04
Completion
2004-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Clonazepam Small molecule 1 mg Oral

Indications

No indication recorded.